Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
J Thorac Oncol. 2024 Mar 8:S1556-0864(24)00117-5. doi: 10.1016/j.jtho.2024.03.010. Online ahead of print.
J Thorac Oncol. 2024.
PMID: 38461929
Free article.
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Cameron RB, Hines JB, Torri V, Porcu L, Donington J, Bestvina CM, Vokes E, Dolezal JM, Esposito A, Garassino MC.
Cameron RB, et al. Among authors: hines jb.
Ther Adv Med Oncol. 2023 Sep 15;15:17588359231198446. doi: 10.1177/17588359231198446. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37720499
Free PMC article.
Review.
Item in Clipboard
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.
Hines JB, Bowar B, Levine E, Esposito A, Garassino MC, Bestvina CM.
Hines JB, et al.
Int J Mol Sci. 2023 May 29;24(11):9429. doi: 10.3390/ijms24119429.
Int J Mol Sci. 2023.
PMID: 37298380
Free PMC article.
Review.
Item in Clipboard
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy.
Hines JB, Kacew AJ, Sweis RF.
Hines JB, et al.
Curr Oncol Rep. 2023 Mar;25(3):189-199. doi: 10.1007/s11912-023-01361-0. Epub 2023 Jan 27.
Curr Oncol Rep. 2023.
PMID: 36705879
Free PMC article.
Review.
Item in Clipboard
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
Dinnon KH 3rd, Leist SR, Okuda K, Dang H, Fritch EJ, Gully KL, De la Cruz G, Evangelista MD, Asakura T, Gilmore RC, Hawkins P, Nakano S, West A, Schäfer A, Gralinski LE, Everman JL, Sajuthi SP, Zweigart MR, Dong S, McBride J, Cooley MR, Hines JB, Love MK, Groshong SD, VanSchoiack A, Phelan SJ, Liang Y, Hether T, Leon M, Zumwalt RE, Barton LM, Duval EJ, Mukhopadhyay S, Stroberg E, Borczuk A, Thorne LB, Sakthivel MK, Lee YZ, Hagood JS, Mock JR, Seibold MA, O'Neal WK, Montgomery SA, Boucher RC, Baric RS.
Dinnon KH 3rd, et al. Among authors: hines jb.
Sci Transl Med. 2022 Sep 28;14(664):eabo5070. doi: 10.1126/scitranslmed.abo5070. Epub 2022 Sep 28.
Sci Transl Med. 2022.
PMID: 35857635
Free PMC article.
Item in Clipboard
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.
Dinnon KH 3rd, Leist SR, Okuda K, Dang H, Fritch EJ, Gully KL, De la Cruz G, Evangelista MD, Asakura T, Gilmore RC, Hawkins P, Nakano S, West A, Schäfer A, Gralinski LE, Everman JL, Sajuthi SP, Zweigart MR, Dong S, McBride J, Cooley MR, Hines JB, Love MK, Groshong SD, VanSchoiack A, Phelan SJ, Liang Y, Hether T, Leon M, Zumwalt RE, Barton LM, Duval EJ, Mukhopadhyay S, Stroberg E, Borczuk A, Thorne LB, Sakthivel MK, Lee YZ, Hagood JS, Mock JR, Seibold MA, O'Neal WK, Montgomery SA, Boucher RC, Baric RS.
Dinnon KH 3rd, et al. Among authors: hines jb.
bioRxiv [Preprint]. 2022 Feb 15:2022.02.15.480515. doi: 10.1101/2022.02.15.480515.
bioRxiv. 2022.
PMID: 35194605
Free PMC article.
Preprint.
Item in Clipboard
Phase I trial of 5-fluorouracil by 24-hour infusion weekly.
Haas NB, Hines JB, Hudes GR, Johnston N, Ozols RF, O'Dwyer PJ.
Haas NB, et al. Among authors: hines jb.
Invest New Drugs. 1993 May-Aug;11(2-3):181-5. doi: 10.1007/BF00874152.
Invest New Drugs. 1993.
PMID: 8262730
Clinical Trial.
Item in Clipboard
Cite
Cite